The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells
Open accessAbstract
The alternative or properdin pathway of complement is primarily controlled by the endopeptidase C3b inactivator (C3bINA) and the nonproteolytic glycoprotein β1H. The molecular mechanisms of control were investigated by performing binding studies of radiolabeled complement proteins to C3b bearing sheep erythrocytes (E S C3b). C3b was found to have distinct binding sites for β1H, C3bINA, Factor B, and properdin. β1H binding increased C3bINA binding 30-fold, while Factor B binding prevented C3bINA action on C3b and was competitive with β1H binding. Properdin binding, which facilitates Factor B interaction with C3b, had no effect on the β1H and C3bINA sites. Activators such as rabbit erythrocytes (E R ) have previously been shown to interfere with the effectiveness of the control by C3bINA and β1H, thereby allowing unrestricted formation of C3 convertase. Such restriction of control does not occur on the surface of E S , a nonactivator of the alternative pathway. On the basis of comparative binding studies, restriction of control is explained entirely by reduced binding of β1H to E R C3b relative to E S C3b. Access of properdin, Factor B, C3bINA, and the Fab fragment of anti-C3 to the two cell types was unrestricted. Restriction of β1H control could be generated on the surface of E S by removal of cell-surface sialic acid with neuraminidase (acylneuraminyl hydrolase; EC 3.2.1.18). This enzymatic treatment converted E S from a nonactivator to an activator of the alternative pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Thiobarbituric Acid Assay of Sialic Acids
Warren, L. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69851-5 · Cited by 6,433
Bolton, A. E., & Hunter, W. M. (1973) · Biochemical Journal · doi:10.1042/bj1330529 · Cited by 3,254
(1962) · Postgraduate Medical Journal · doi:10.1136/pgmj.38.436.126-a · Cited by 1,457
Pillemer, L., Blum, L., Lepow, I. H., Ross, O. A., Todd, E. W., & Wardlaw, A. C. (1954) · Science · doi:10.1126/science.120.3112.279 · Cited by 938
Nisonoff, A., Wissler, F. C., Lipman, L. N., & Woernley, D. L. (1960) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(60)90049-7 · Cited by 936
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.1.257 · Cited by 684
Self-citationModulation of the alternative complement pathways by beta 1 H globulin.
Whaley, K., & Ruddy, S. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.5.1147 · Cited by 583
Control of the amplification convertase of complement by the plasma protein beta1H.
Weiler, J. M., Daha, M. R., Austen, K. F., & Fearon, D. T. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3268 · Cited by 570
Third component of human complement: purification from plasma and physicochemical characterization
Tack, B. F., & Prahl, J. W. (1976) · Biochemistry · doi:10.1021/bi00665a028 · Cited by 516
C3 PROACTIVATOR CONVERTASE AND ITS MODE OF ACTION
Müller-Eberhard, H. J., & Götze, O. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.135.4.1003 · Cited by 324
Activation of the alternative complement pathway due to resistance of zymosan-bound.
Fearon, D. T., & Austen, K. F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.4.1683 · Cited by 284
Medicus, R. G., Götze, O., & Müller-Eberhard, H. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.4.1076 · Cited by 205
Self-citationFearon, D., & Austen, K. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.22 · Cited by 177
Lachmann, P. J., & Halbwachs‐Mecarelli, L. (1975) · PubMed · Cited by 173
Schreiber, R. D., Götze, O., & Müller‐Eberhard, H. J. (1976) · The Journal of Experimental Medicine · doi:10.1084/jem.144.4.1062 · Cited by 60
Self-citation
Cited by
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary Perspective
Angata, T., & Varki, A. (2002) · Chemical Reviews · doi:10.1021/cr000407m · Cited by 1,237
Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins
Varki, A. (2007) · Nature · doi:10.1038/nature05816 · Cited by 853
Multifarious roles of sialic acids in immunity
Varki, A., & Gagneux, P. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06517.x · Cited by 611
Metadata
- Authors
- Pangburn, M. K., & Müller-Eberhard, H. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1978-05
- Volume
- 75
- Issue
- 5
- Pages
- 2416-2420
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1989222495
- Cited by
- 346
- References
- 15
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.